Insulet (PODD) Tops Q4 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Insulet Corporation (PODD) PT Lowered to $310 at BTIG
February 24, 2022 12:59 PM ESTBTIG analyst Marie Thibault lowered the price target on Insulet Corporation (NASDAQ: PODD) to $310.00 (from $320.00) while maintaining a Buy rating.
The analyst commented, "Insulet reported Q4 revenue of $307.7M (+25% y/y rep, +25.7% y/y cc), beating consensus estimates of $299.3M and our $303.2M forecast. U.S. Omnipod revenue was relatively in line with our expectations but OUS headwinds, including ongoing pressures from competitive AID systems and an estimated $5M... More



